Volume 15, Number 1—January 2009
Letter
Clostridium difficile–related Hospitalizations among US Adults, 2006
Table
Hospitalization variable | Year |
||||||
---|---|---|---|---|---|---|---|
2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | |
All US adults per 10,000 population | |||||||
18–44 y | 1.31 | 1.33 | 1.66 | 1.71 | 1.96 | 2.26 | 2.39 |
45–64 y | 4.53 | 4.58 | 5.92 | 6.31 | 7.20 | 8.48 | 9.09 |
65–84 y | 22.41 | 23.94 | 31.61 | 33.74 | 39.06 | 46.57 | 48.96 |
>85 y |
52.09 |
57.03 |
70.15 |
74.99 |
89.39 |
110.71 |
111.70 |
Principal diagnosis CDAD as a proportion of total CDAD, % | |||||||
18–44 y | 26.3 | 26.8 | 26.9 | 26.1 | 28.1 | 29.1 | 30.7 |
45–64 y | 24.4 | 25.2 | 24.4 | 23.2 | 24.3 | 25.5 | 27.4 |
65–84 y | 22.8 | 23.7 | 23.3 | 22.8 | 23.8 | 24.9 | 27.8 |
>85 y |
22.1 |
24.4 |
23.6 |
23.2 |
24.0 |
25.0 |
29.8 |
By sex per 10,000 population | |||||||
M | 4.10 | 6.30 | 5.71 | 6.03 | 7.03 | 8.59 | 9.00 |
F |
5.72 |
6.83 |
7.71 |
8.32 |
9.71 |
11.72 |
12.29 |
By sex per 1,000 hospitalizations | |||||||
M | 3.83 | 5.81 | 5.24 | 5.54 | 6.43 | 7.79 | 8.13 |
F |
3.81 |
4.51 |
5.04 |
5.45 |
6.36 |
7.66 |
8.02 |
Regionally per 10,000 population | |||||||
Northeast | 7.05 | 7.59 | 9.30 | 10.40 | 10.73 | 14.46 | 14.28 |
Midwest | 5.70 | 5.32 | 7.96 | 8.51 | 9.86 | 11.32 | 12.27 |
South | 4.05 | 4.98 | 6.26 | 6.49 | 8.19 | 9.50 | 9.64 |
West |
3.72 |
3.52 |
4.10 |
4.39 |
5.39 |
6.73 |
7.32 |
Regionally per 1,000 hospitalizations | |||||||
Northeast | 5.15 | 5.52 | 6.74 | 7.47 | 7.64 | 10.17 | 10.00 |
Midwest | 4.36 | 3.98 | 5.90 | 6.31 | 7.26 | 8.26 | 8.97 |
South | 2.97 | 3.59 | 4.49 | 4.66 | 5.89 | 6.83 | 7.06 |
West | 3.41 | 3.24 | 3.76 | 4.00 | 4.92 | 6.16 | 6.85 |
*CDAD, C. difficile–associated disease.
Page created: December 06, 2010
Page updated: December 06, 2010
Page reviewed: December 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.